🚨 IVERMECTIN IS BACK IN THE CANCER RESEARCH CONVERSATION Ivermectin is once again attracting attention beyond its established antiparasitic uses, this time through cancer research, drug repurposing, and dermatology. In September 2025, Florida announced a $60 million funding